Merganser Biotech, Inc. — Form D/A
Merganser Biotech, Inc. of King of Prussia, PA, a company, filed a Form D amendment with the SEC on 2016-04-29. The offering totals $17.1M, of which $13.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-04-29
- Form: D/A
- Accession: 0001635172-16-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $17.1M
- Amount sold: $13.1M
- Remaining: $4.0M
- Investors: 24
- Date of first sale: 2015-02-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-234935
Issuer
- Name: Merganser Biotech, Inc.
- CIK: 0001635172
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 1004 West 9th Avenue, Suite 115, King of Prussia, PA, 19406
- Phone: 484-590-5290
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Jeffrey Bird | Director | San Mateo, CA |
| Colin Goddard | Director | JUPITER, FL |
| Markus Goebel | Director | Sunnyvale, CA |
| Brian MacDonald | Director | Carlsbad, CA |
| James Topper | Director | La Jolla, CA |
| Brian MacDonald | Executive Officer | Carlsbad, CA |
| Remy Sukhija | Executive Officer | King of Prussia, PA |
Other filings by this issuer (1)
More